David Tanen is a Co-Founder and Partner of Two River, which focuses on creating, operating and financing development stage life science companies. Prior to founding Two River, he served as General Counsel of a life science focused venture capital firm. David is also a Co-Founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel before its acquisition by Gilead Sciences in 2017. He is a Co-Founder and Corporate Secretary of Allogene Therapeutics, Inc. David is Advisor to Vida Ventures. David received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.